I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5 Febuxostat Intermediate Purity >99.0% Factory

Incazelo emfushane:

Igama Lekhemikhali: Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate

I-CAS: 161797-99-5

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Okuphuzi Okukhanyayo kuya Kumpushana Ongamhlophe

I-Intermediate ye-Febuxostat (CAS: 144060-53-7)

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate
Omqondofana Febuxostat Intermediate
Inombolo ye-CAS 161797-99-5
Inombolo yeCAT I-RF-PI1122
Isimo Sesitoko Esitokweni, Amandla Okukhiqiza Amathani ayi-100/Ngonyaka
I-Molecular Formula I-C13H13NO3S
Isisindo samangqamuzana 263.31
I-Melting Point 180 ℃
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Ephuzi Okukhanyayo ukuya kokumhlophe
Ukuhlonza Nge-HPLC;Ibhalwe ngu-HNMR
Ukulahlekelwa Ekumisweni <0.50%
Izinsalela ku-Ighition <0.30%
Ukungcola Okukodwa <0.50%
Ukungcola Okuphelele <1.00%
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (nge-HPLC)
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Febuxostat (CAS: 144060-53-7)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) isetshenziswa ekuhlanganiseni kwe-Febuxostat (CAS: 144060-53-7), i-xanthine oxidase/xanthine dehydrogenase inhibitor.Isetshenziselwa ukwelapha i-hyperuricemia kanye ne-gout engapheli.I-40-120 mg/ngosuku i-febuxostat yafakazelwa ukuthi iyasebenza ekwehliseni amazinga e-serum urate lapho isetshenziswa ukuphatha i-hyperuricemia ezigulini ezine-gout.I-Fabuxostat itholwe yi-Teijin Pharmaceuticals futhi yanikezwa ilayisense ye-TAP Pharmaceuticals (okwamanje eyingxenye ye-Takeda Pharmaceuticals) futhi yagunyazwa e-US ukuze zelashwe i-hyperuricemia ezigulini ezine-gout.

Bhala umyalezo wakho lapha futhi usithumelele wona